Pinto Joshua

Insider profile

Performance

Overall performance

Performance over holding periods
30 days 90 days 120 days
Average return 27% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Pinto Joshua's trades of Neumora Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-02-19 2026-02-17 S Sale
57,257 -10.3%
184.82
US$3,667,872
57,257 -10.3% 184.82 US$3,667,872
2026-02-17 2026-02-17 PrS Proposed sale
8,006
196.23
US$1,539,549
8,006 196.23 US$1,539,549
2025-02-20 2025-02-18 PlS Planned sale
54,929 -1.0%
340.09
US$4,098,099
54,929 -1.0% 340.09 US$4,098,099
2025-02-18 2025-02-18 PrS Proposed sale
8,048
1.67
US$13,478
8,048 1.67 US$13,478
2024-08-27 2024-08-27 PlS Planned sale
15,693 -10.1%
11.39
US$178,806
15,693 -10.1% 11.39 US$178,806
2024-08-26 2024-08-26 PlS Planned sale
31,642 -17.0%
11.78
US$372,588
31,642 -17.0% 11.78 US$372,588
2024-08-26 2024-08-23 PlS Planned sale
24,169 -11.5%
11.59
US$280,005
24,169 -11.5% 11.59 US$280,005
2024-08-26 2024-08-22 PlS Planned sale
28,496 -11.9%
11.63
US$331,468
28,496 -11.9% 11.63 US$331,468
2024-08-22 2024-08-22 PrS Proposed sale
100,000
11.90
US$1,190,000
100,000 11.90 US$1,190,000